Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Active funds frequently lag behind due to fees and manager risk, while index funds provide broad exposure with lower costs and smoother performance.
22,686 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Salesforce stock faces a pivotal year as AI-enhanced CRM and cloud strategy shape the upside. Here's the latest marke...
Milan rolls out a modern Olympic stadium and hundreds of new homes, a move officials say primes the city for sustaine...
When a global pop star talks about blocking artists on Spotify, it’s more than a mood—it’s a real-world lesson in bud...
IonQ stunned traders with a sharp rally after reporting stronger-than-expected 2025 results and a robust 2026 revenue...
Solana posted the largest ETF inflow in months on February 25, signaling renewed institutional interest. Yet on-chain...
Bitcoin, XRP, and Ethereum show renewed momentum as markets digest regulatory chatter and macro signals. This update ...
What the arcturus (arct) 2025 earnings report may reveal isn’t just about a single quarter. This guide breaks down th...
A new look at the equipment carried by WWII paratroopers sheds light on how historical burdens shape modern defense b...
XRP ETFs have drawn swollen inflows since November, yet the price remains soft. Analysts say a multi-billion dollar r...
California prices could soon surge past seven dollars per gallon as crude costs climb and refining limits bite, with ...
Global markets surged after President Trump hinted at de-escalation in Iran, easing oil risks and boosting equities. ...